Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,468 | 81 | 99.5% |
| Education | $6.98 | 2 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $292.56 | 17 | $0 (2020) |
| Otsuka America Pharmaceutical, Inc. | $210.01 | 13 | $0 (2024) |
| Shire North American Group Inc | $197.53 | 13 | $0 (2018) |
| Allergan Inc. | $122.97 | 10 | $0 (2017) |
| Neos Therapeutics, LP | $112.10 | 6 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $90.40 | 3 | $0 (2024) |
| Takeda Pharmaceuticals America, Inc. | $79.37 | 2 | $0 (2017) |
| Neurocrine Biosciences, Inc. | $70.21 | 3 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $60.85 | 3 | $0 (2017) |
| ABBVIE INC. | $47.98 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $155.75 | 6 | Neurocrine Biosciences, Inc. ($54.94) |
| 2023 | $37.52 | 1 | Janssen Pharmaceuticals, Inc ($37.52) |
| 2022 | $42.92 | 2 | ABBVIE INC. ($23.45) |
| 2021 | $24.53 | 1 | AbbVie Inc. ($24.53) |
| 2020 | $40.78 | 2 | Sunovion Pharmaceuticals Inc. ($40.78) |
| 2019 | $77.01 | 4 | Sunovion Pharmaceuticals Inc. ($42.30) |
| 2018 | $47.31 | 3 | Sunovion Pharmaceuticals Inc. ($33.77) |
| 2017 | $1,049 | 64 | Otsuka America Pharmaceutical, Inc. ($185.05) |
All Payment Transactions
83 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/24/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $30.56 | General |
| Category: Neuropsychiatry | ||||||
| 09/19/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $22.97 | General |
| Category: Neurology | ||||||
| 07/25/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $28.35 | General |
| Category: Neuroscience | ||||||
| 05/15/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: Neuroscience | ||||||
| 05/02/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug) | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: PSYCHIATRY | ||||||
| 03/22/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: Neuropsychiatry | ||||||
| 09/21/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $37.52 | General |
| Category: Neuroscience | ||||||
| 06/16/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: PSYCHIATRY | ||||||
| 04/21/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2020 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: CNS | ||||||
| 06/11/2020 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: CNS | ||||||
| 12/12/2019 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: CNS | ||||||
| 11/20/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $23.04 | General |
| Category: CNS | ||||||
| 05/01/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: CNS | ||||||
| 04/11/2019 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: NEUROLOGY | ||||||
| 11/29/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: CNS | ||||||
| 08/29/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: CNS | ||||||
| 01/24/2018 | Shire North American Group Inc | MYDAYIS (Drug) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: NEUROSCIENCE | ||||||
| 12/14/2017 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug) | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: ADHD | ||||||
| 12/12/2017 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $10.60 | General |
| Category: NEUROSCIENCE | ||||||
| 12/01/2017 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: CNS | ||||||
| 11/15/2017 | Shire North American Group Inc | MYDAYIS (Drug) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2017 | Shire North American Group Inc | MYDAYIS (Drug) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2017 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug) | Food and Beverage | In-kind items and services | $2.06 | General |
| Category: ADHD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 93 | 843 | $108,167 | $37,130 |
| 2022 | 3 | 120 | 804 | $94,183 | $27,349 |
| 2021 | 1 | 21 | 96 | $10,560 | $2,776 |
| 2020 | 4 | 82 | 325 | $40,869 | $12,636 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 43 | 676 | $80,600 | $25,891 | 32.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 15 | 131 | $18,969 | $7,950 | 41.9% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2023 | 15 | 15 | $4,440 | $1,964 | 44.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 20 | 21 | $4,158 | $1,324 | 31.8% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 71 | 754 | $82,940 | $22,816 | 27.5% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2022 | 23 | 23 | $6,302 | $3,004 | 47.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 26 | 27 | $4,941 | $1,530 | 31.0% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 21 | 96 | $10,560 | $2,776 | 26.3% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 40 | 281 | $30,910 | $8,853 | 28.6% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2020 | 16 | 17 | $4,658 | $1,912 | 41.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 12 | 12 | $2,556 | $981.08 | 38.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 14 | 15 | $2,745 | $889.97 | 32.4% |
About Dr. Rohan Gopalani, MD
Dr. Rohan Gopalani, MD is a Child & Adolescent Psychiatry healthcare provider based in Ambler, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/30/2007. The National Provider Identifier (NPI) number assigned to this provider is 1972640183.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rohan Gopalani, MD has received a total of $1,475 in payments from pharmaceutical and medical device companies, with $155.75 received in 2024. These payments were reported across 83 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($1,468).
As a Medicare-enrolled provider, Gopalani has provided services to 316 Medicare beneficiaries, totaling 2,068 services with total Medicare billing of $79,891. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Practice Information
- Specialty Child & Adolescent Psychiatry
- Location Ambler, PA
- Active Since 01/30/2007
- Last Updated 07/18/2011
- Taxonomy Code 2084P0804X
- Entity Type Individual
- NPI Number 1972640183
Products in Payments
- LATUDA (Drug) $292.56
- VRAYLAR (Drug) $170.95
- VYVANSE (Drug) $112.86
- Adzenys XR-ODT (Drug) $112.10
- ABILIFY MAINTENA (Drug) $108.78
- INVEGA SUSTENNA (Drug) $90.40
- MYDAYIS (Drug) $84.67
- Trintellix (Drug) $79.37
- REXULTI (Drug) $76.27
- INGREZZA (Drug) $70.21
- Fanapt (Drug) $38.57
- Aptensio XR (Drug) $34.33
- ABILIFY ASIMTUFII (Drug) $24.96
- Aristada 441 mg (Drug) $24.38
- UZEDY (Drug) $22.97
- BELSOMRA (Drug) $21.20
- CAPLYTA (Drug) $19.47
- ARISTADA (Drug) $19.44
- QUILLICHEW ER (Drug) $18.51
- TRINTELLIX (Drug) $16.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Child & Adolescent Psychiatry Doctors in Ambler
Andrew Simonson, M.d, M.D
Child & Adolescent Psychiatry — Payments: $845.37
Umadevi Nuthi, M.d, M.D
Child & Adolescent Psychiatry — Payments: $174.39
Jagruti Amin, M.d, M.D
Child & Adolescent Psychiatry — Payments: $112.48
Mr. Ryan Vesny, Md, MD
Child & Adolescent Psychiatry — Payments: $22.19
Nancy Cox, M.d, M.D
Child & Adolescent Psychiatry